256 related articles for article (PubMed ID: 27528232)
1. PPARγ agonists promote differentiation of cancer stem cells by restraining YAP transcriptional activity.
Basu-Roy U; Han E; Rattanakorn K; Gadi A; Verma N; Maurizi G; Gunaratne PH; Coarfa C; Kennedy OD; Garabedian MJ; Basilico C; Mansukhani A
Oncotarget; 2016 Sep; 7(38):60954-60970. PubMed ID: 27528232
[TBL] [Abstract][Full Text] [Related]
2. Sox2 antagonizes the Hippo pathway to maintain stemness in cancer cells.
Basu-Roy U; Bayin NS; Rattanakorn K; Han E; Placantonakis DG; Mansukhani A; Basilico C
Nat Commun; 2015 Apr; 6():6411. PubMed ID: 25832504
[TBL] [Abstract][Full Text] [Related]
3. [Regulation of differentiation of mesenchymal stem cells by the Hippo pathway effectors TAZ/YAP].
Men T; Piao SH; Teng CB
Yi Chuan; 2013 Nov; 35(11):1283-90. PubMed ID: 24579311
[TBL] [Abstract][Full Text] [Related]
4. Direct conversion of osteosarcoma to adipocytes by targeting TNIK.
Hirozane T; Masuda M; Sugano T; Sekita T; Goto N; Aoyama T; Sakagami T; Uno Y; Moriyama H; Sawa M; Asano N; Nakamura M; Matsumoto M; Nakayama R; Kondo T; Kawai A; Kobayashi E; Yamada T
JCI Insight; 2021 Feb; 6(3):. PubMed ID: 33400690
[TBL] [Abstract][Full Text] [Related]
5. Hippo/YAP signaling pathway is involved in osteosarcoma chemoresistance.
Wang DY; Wu YN; Huang JQ; Wang W; Xu M; Jia JP; Han G; Mao BB; Bi WZ
Chin J Cancer; 2016 May; 35():47. PubMed ID: 27206784
[TBL] [Abstract][Full Text] [Related]
6. PPARγ and Wnt Signaling in Adipogenic and Osteogenic Differentiation of Mesenchymal Stem Cells.
Yuan Z; Li Q; Luo S; Liu Z; Luo D; Zhang B; Zhang D; Rao P; Xiao J
Curr Stem Cell Res Ther; 2016; 11(3):216-25. PubMed ID: 25986621
[TBL] [Abstract][Full Text] [Related]
7. PAR1 participates in the ability of multidrug resistance and tumorigenesis by controlling Hippo-YAP pathway.
Fujimoto D; Ueda Y; Hirono Y; Goi T; Yamaguchi A
Oncotarget; 2015 Oct; 6(33):34788-99. PubMed ID: 26431277
[TBL] [Abstract][Full Text] [Related]
8. Statin suppresses Hippo pathway-inactivated malignant mesothelioma cells and blocks the YAP/CD44 growth stimulatory axis.
Tanaka K; Osada H; Murakami-Tonami Y; Horio Y; Hida T; Sekido Y
Cancer Lett; 2017 Jan; 385():215-224. PubMed ID: 27773750
[TBL] [Abstract][Full Text] [Related]
9. Hippo/Yap signaling controls epithelial progenitor cell proliferation and differentiation in the embryonic and adult lung.
Lange AW; Sridharan A; Xu Y; Stripp BR; Perl AK; Whitsett JA
J Mol Cell Biol; 2015 Feb; 7(1):35-47. PubMed ID: 25480985
[TBL] [Abstract][Full Text] [Related]
10. Cultured Human Periosteum-Derived Cells Can Differentiate into Osteoblasts in a Perioxisome Proliferator-Activated Receptor Gamma-Mediated Fashion via Bone Morphogenetic Protein signaling.
Chung JE; Park JH; Yun JW; Kang YH; Park BW; Hwang SC; Cho YC; Sung IY; Woo DK; Byun JH
Int J Med Sci; 2016; 13(11):806-818. PubMed ID: 27877072
[TBL] [Abstract][Full Text] [Related]
11. SOX2 regulates YAP1 to maintain stemness and determine cell fate in the osteo-adipo lineage.
Seo E; Basu-Roy U; Gunaratne PH; Coarfa C; Lim DS; Basilico C; Mansukhani A
Cell Rep; 2013 Jun; 3(6):2075-87. PubMed ID: 23791527
[TBL] [Abstract][Full Text] [Related]
12. TEAD1 mediates the oncogenic activities of Hippo-YAP1 signaling in osteosarcoma.
Chai J; Xu S; Guo F
Biochem Biophys Res Commun; 2017 Jun; 488(2):297-302. PubMed ID: 28483529
[TBL] [Abstract][Full Text] [Related]
13. Developmental pathways hijacked by osteosarcoma.
Mortus JR; Zhang Y; Hughes DP
Adv Exp Med Biol; 2014; 804():93-118. PubMed ID: 24924170
[TBL] [Abstract][Full Text] [Related]
14. ROCK2 deprivation leads to the inhibition of tumor growth and metastatic potential in osteosarcoma cells through the modulation of YAP activity.
Zucchini C; Manara MC; Cristalli C; Carrabotta M; Greco S; Pinca RS; Ferrari C; Landuzzi L; Pasello M; Lollini PL; Gambarotti M; Donati DM; Scotlandi K
J Exp Clin Cancer Res; 2019 Dec; 38(1):503. PubMed ID: 31878963
[TBL] [Abstract][Full Text] [Related]
15. Dexamethasone and rosiglitazone are sufficient and necessary for producing functional adipocytes from mesenchymal stem cells.
Contador D; Ezquer F; Espinosa M; Arango-Rodriguez M; Puebla C; Sobrevia L; Conget P
Exp Biol Med (Maywood); 2015 Sep; 240(9):1235-46. PubMed ID: 25595190
[TBL] [Abstract][Full Text] [Related]
16. Wnt signaling stimulates osteoblastogenesis of mesenchymal precursors by suppressing CCAAT/enhancer-binding protein alpha and peroxisome proliferator-activated receptor gamma.
Kang S; Bennett CN; Gerin I; Rapp LA; Hankenson KD; Macdougald OA
J Biol Chem; 2007 May; 282(19):14515-24. PubMed ID: 17351296
[TBL] [Abstract][Full Text] [Related]
17. Liraglutide suppresses proliferation and induces adipogenic differentiation of 3T3-L1 cells via the Hippo-YAP signaling pathway.
Li Y; Du J; Zhu E; Zhang J; Han J; Zhao W; Sun B; Tian D
Mol Med Rep; 2018 Mar; 17(3):4499-4507. PubMed ID: 29344656
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide analysis of N1ICD/RBPJ targets in vivo reveals direct transcriptional regulation of Wnt, SHH, and hippo pathway effectors by Notch1.
Li Y; Hibbs MA; Gard AL; Shylo NA; Yun K
Stem Cells; 2012 Apr; 30(4):741-52. PubMed ID: 22232070
[TBL] [Abstract][Full Text] [Related]
19. Yap-dependent reprogramming of Lgr5(+) stem cells drives intestinal regeneration and cancer.
Gregorieff A; Liu Y; Inanlou MR; Khomchuk Y; Wrana JL
Nature; 2015 Oct; 526(7575):715-8. PubMed ID: 26503053
[TBL] [Abstract][Full Text] [Related]
20. Differential gene regulation by PPARgamma agonist and constitutively active PPARgamma2.
Li Y; Lazar MA
Mol Endocrinol; 2002 May; 16(5):1040-8. PubMed ID: 11981038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
